These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 445521)
1. Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas. Bunn PA; Lamberg SI Cancer Treat Rep; 1979 Apr; 63(4):725-8. PubMed ID: 445521 [No Abstract] [Full Text] [Related]
4. A practical approach to accurate classification and staging of mycosis fungoides and Sézary syndrome. Thomas BR; Whittaker S Skin Therapy Lett; 2012 Dec; 17(10):5-9. PubMed ID: 23223768 [TBL] [Abstract][Full Text] [Related]
5. Report of the Committee on Pathology of Cutaneous T Cell Lymphomas. Clendenning WE; Rappaport HW Cancer Treat Rep; 1979 Apr; 63(4):719-24. PubMed ID: 376141 [No Abstract] [Full Text] [Related]
6. A modified staging classification for cutaneous T-cell lymphoma. Kashani-Sabet M; McMillan A; Zackheim HS J Am Acad Dermatol; 2001 Nov; 45(5):700-6. PubMed ID: 11606919 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--Part I. Safai B Clin Bull; 1977; 7(3):91-7. PubMed ID: 308870 [No Abstract] [Full Text] [Related]
8. Clinical features of cutaneous T-cell lymphoma. Abel EA Dermatol Clin; 1985 Oct; 3(4):647-64. PubMed ID: 2878755 [TBL] [Abstract][Full Text] [Related]
9. [Diagnosis of malignant cutaneous lymphomas]. Sterry W Dtsch Med Wochenschr; 1988 Feb; 113(5):184-9. PubMed ID: 3276493 [No Abstract] [Full Text] [Related]
10. Implication of the ras and myc oncoproteins in the pathogenesis of mycosis fungoides. Tosca A; Linardopoulos S; Malliri A; Hatziolou E; Nicolaidou A; Spandidos DA Anticancer Res; 1991; 11(4):1433-8. PubMed ID: 1746900 [TBL] [Abstract][Full Text] [Related]
11. [Alpha interferon in the therapy of cutaneous T cell lymphomas]. Lang MH; Altmeyer P; Lodemann E; Holzmann H Z Hautkr; 1986 May; 61(9):599-608. PubMed ID: 3487184 [TBL] [Abstract][Full Text] [Related]
12. [Epidermotropic T lymphomas]. Sigal-Nahum M; Brousse N; Belaïch S Rev Prat; 1987 May; 37(25):1423-31. PubMed ID: 3495856 [No Abstract] [Full Text] [Related]
13. Is bone marrow biopsy necessary in patients with mycosis fungoides and Sézary syndrome? A histological and molecular study at diagnosis and during follow-up. Beylot-Barry M; Parrens M; Delaunay M; Thiebault R; Vergier B; DeMascarel A; Dubus P; Beylot C; Merlio JP Br J Dermatol; 2005 Jun; 152(6):1378-9. PubMed ID: 15949023 [No Abstract] [Full Text] [Related]
14. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas. Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809 [TBL] [Abstract][Full Text] [Related]
15. [Cutaneous malignant lymphomas]. Ben Romdhane K Tunis Med; 1989; 67(6-7):385-90. PubMed ID: 2678641 [No Abstract] [Full Text] [Related]
16. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides. Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425 [TBL] [Abstract][Full Text] [Related]
17. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe. Grob JJ; Horchowski N; Tubiana N; Gabriel B; Gastaut JA; Hassoun J; Jouve I; Carcassone Y; Bonerandi JJ Dermatologica; 1988; 177(2):82-97. PubMed ID: 3262542 [TBL] [Abstract][Full Text] [Related]
19. [Mycosis fungoides and Sézary syndrome. A retrospective study of 60 patients with correlation between histologic classification and survival time]. Hödl S Z Hautkr; 1986 Jul; 61(14):993-1013. PubMed ID: 3751216 [TBL] [Abstract][Full Text] [Related]